References
- Sigh A. K., Brenner B. M. Dialysis in the treatment of renal failure. Harrison's Principles of Internal Medicine15th Ed., E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, J. L. Jameson. McGraw‐Hill, New York 2001; 1562–1566
- Haynes B. F., Fauci A. S. Disorders of the immune system. Harrison's Principles of Internal Medicine15th Ed., E. Braunwald, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, J. L. Jameson. McGraw‐Hill, New York 2001; 1805–1830
- Shapiro H. M. Practical Flow Cytometry3rd Ed. Wiley‐Liss, New York 1995; 1–517
- Davies S. J., Suassuna J., Ogg C. S., Cameron J. S. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int. 1988; 36: 661–668
- Casciani C. V., DeSimone C., Bonini S. Immunological aspects of chronic uremia. Kidney Int. 1978; 13(Suppl. 8)S49–S54
- Qvadracci L., Ringden O., Krzymanski M. The effect of uremia and transplantation on lymphocyte subpopulations. Kidney Int. 1976; 10: 179–184
- Kamata K., Okubo M., Sada M. Immunosuppressive factors in uremic sera are composed of both dialyzable and non‐dialyzable components. Clin. Exp. Immunol. 1983; 54: 227–281
- Nakhlva L. S., Goggin M. J. Lymphocyte transformation in chronic renal failure. Immunology 1973; 24: 229–235
- Linnemann C., First M. R., Schiffman G. Response to pneumococcal … in renal transplant and hemodialysis patients. Arch. Int. Med. 1981; 141: 1637–1640, [CROSSREF]
- Port I. K. Mortality and causes of death in patients with end stage renal failure. Am. J. Kidney Dis. 1990; 15: 215–217, [PUBMED], [INFOTRIEVE]
- Vas S. L. Peritonitis. Peritoneal Dialysis, K. D. Nolph. Kluwer Academic Publishers, Dordrechtthe Netherlands 1989; 261–288
- Carvounis C. P. Total lymphocyte count: a promising prognostic index of mortality in patients on CAPD. Perit. Dial. Int. 2000; 20: 33–38, [PUBMED], [INFOTRIEVE]
- Mota E., Orfao A., Mota M., Georgescu. Lymphocyte subpopulations and urinary infection in the patients with diabetic nephropathy treated by CAPD. Proceedings of the XXXVII Congress of the European Renal Association. European Dialysis and Transplantation Association, NiceFrance September, 2000; 17–20
- Shohat B. Cell mediated immunity in uremic patients prior to and after 6 months treatment with continuous ambulatory peritoneal dialysis. Isr. J. Med. Sci. 1986; 22: 551–555, [PUBMED], [INFOTRIEVE]
- Grezegorzewska A. E. Lymphocyte subsets in the course of CAPD. Adv. Perit. Dial. 2001; 17: 10–14
- Pereira B. J. Cytokine production in patients on dialysis. Blood Purif. 1995; 13: 135–146, [PUBMED], [INFOTRIEVE]
- Cala S. Negative effect of uremia and cuprophane hemodialysis on natural killer cells. Nephrol. Dial. Transplant. 1990; 5: 437–440, [PUBMED], [INFOTRIEVE]
- Whiteside T. L., Herberman R. B. The role of natural killer cells in human disease. Clin. Immunol. Immunopathol. 1989; 53: 1–23, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Palop L., Martinez J. A. Cross‐sectional assessment of nutritional and immune status in renal patients undergoing CAPD. Am. J. Clin. Nutr. 1997; 66: 498–503
- Langoff E. In vitro natural killer and killer functions in uremia. Int. Arch. Allergy Appl. Immunol. 1985; 78: 218–220
- Hayakama M., Hatano T., Sunabe T., Higa I., Osawa A. Cytokine production and cytoxicity of lymphocytes in patients on maintenance short or long‐term hemodialysis. Nephrol. Dial. Transplant. 1994; 9: 655–661
- Wiener D., Shah S., Malone J., Lowell N., Lowitt S., Rowlands D. T., Jr. Multiparametric analysis of peripheral blood in the normal pediatric population by flow cytometry. J. Clin. Lab. Anal. 1990; 4: 175–179, [PUBMED], [INFOTRIEVE]
- Santagostino A., Garbaccio G., Pistorio A., Bolis V., Camisasca G., Pagliano B., Girotto M. An Italian national multicenter study for the definition of a reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Hematologica 1999; 84: 499–504